EUVIMEDEUVIMED entdecken
Crossref

Assessment of Serum 25-hydroxyvitamin D Levels at the First Manifestation of Multiple Sclerosis in Children and Adolescents

Müge Ayanoğlu, Ayşe Tosun

Trends in Pediatrics · 2022

DOI: 10.4274/tp.2022.59144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Pediatrics, 2022. Verfasst von Müge Ayanoğlu und 1 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate serum 25-hydroxyvitamin D levels, demographic features, and anthropometric measurements at the first manifestation of disease in children and adolescents with multiple sclerosis (MS).

Methods

This retrospective study included patients with MS and healthy children and adolescents. Children and adolescents whose clinical and radiological findings were compatible with the McDonald 2017 criteria and who had vitamin D results during the first relapse were included. Having an acute or chronic disease was an exclusion criterion for healthy controls. Taking a supplementation including vitamin D is an exclusion criterion for both the MS and control groups. Age, gender, anthropometric measurements, and serum levels of 25-hydroxyvitamin D were extracted from the database.

Results

A total of 23 patients (female: 17, 73.9%) and 24 (female: 12, 50.0%) healthy children and adolescents were included. The median ages of the patient group and the control group were 16.33 (2.00), and 15.36 (2.29), respectively. There were no significant differences between the groups in terms of age, gender, weight-standard deviation score (SDS), height-SDS, and body mass index-SDS. Precisely, 87.0% of the patients had a vitamin D deficiency. The mean vitamin D values of the patients and the healthy controls were 12.76±5.52, and 18.75±5.86, respectively. Patients with MS had significantly lower levels of 25-hydroxyvitamin D than healthy controls (p

Zitieren

APA

Ayanoğlu, M., & Tosun, A. (2022). Assessment of Serum 25-hydroxyvitamin D Levels at the First Manifestation of Multiple Sclerosis in Children and Adolescents. Trends in Pediatrics. https://doi.org/10.4274/tp.2022.59144

Vancouver

Ayanoğlu M, Tosun A. Assessment of Serum 25-hydroxyvitamin D Levels at the First Manifestation of Multiple Sclerosis in Children and Adolescents. Trends in Pediatrics. 2022. doi:10.4274/tp.2022.59144

BibTeX
@article{Ayanolu2022,
  author = {Ayanoğlu, Müge and Tosun, Ayşe},
  title = {Assessment of Serum 25-hydroxyvitamin D Levels at the First Manifestation of Multiple Sclerosis in Children and Adolescents},
  journal = {Trends in Pediatrics},
  year = {2022},
  doi = {10.4274/tp.2022.59144}
}
Kostenlos starten →